Shilanski & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,908
| Closed | -$584K | – | 112 |
|
|
2024
Q3 | $584K | Sell |
4,908
-230
| -4% | -$27.4K | 0.19% | 61 |
|
|
2024
Q2 | $733K | Sell |
5,138
-279
| -5% | -$39.8K | 0.25% | 63 |
|
|
2024
Q1 | $698K | Buy |
5,417
+320
| +6% | +$41.3K | 0.24% | 63 |
|
|
2023
Q4 | $527K | Sell |
5,097
-228
| -4% | -$23.6K | 0.2% | 64 |
|
|
2023
Q3 | $484K | Sell |
5,325
-155
| -3% | -$14.1K | 0.2% | 68 |
|
|
2023
Q2 | $443K | Buy |
5,480
+28
| +0.5% | +$2.27K | 0.18% | 73 |
|
|
2023
Q1 | $430K | Sell |
5,452
-6
| -0.1% | -$474 | 0.19% | 71 |
|
|
2022
Q4 | $369K | Buy |
+5,458
| New | +$369K | 0.16% | 74 |
|
|
2022
Q3 | – | Sell |
-5,204
| Closed | -$290K | – | 193 |
|
|
2022
Q2 | $290K | Buy |
5,204
+64
| +1% | +$3.57K | 0.14% | 81 |
|
|
2022
Q1 | $287K | Buy |
5,140
+662
| +15% | +$37K | 0.12% | 92 |
|
|
2021
Q4 | $251K | Buy |
+4,478
| New | +$251K | 0.11% | 96 |
|